Stay updated with breaking news from Pharming Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- The "Tissue Sealants Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023...
(2024-01-08) Pharming Group announces updated full year 2023 guidance and Joenja® U.S. launch update
Pharming Group N.V. (PHAR) announced, for the full year 2023, total revenues are expected to increase by 19% to approximately $245 million. For 2023, the company expects RUCONEST revenues to increase by 10% to approximately $227 million.
- No change to macro narrative over the weekend, following the beat in US nonfarm payrolls on Fri.
Leukocyte Adhesion Deficiency Management IndustryThe global leukocyte adhesion deficiency management industry size is expected to reach a valuation of US$ 8.09 billion in 2023 and is projected to reach US$ 15.2 billion by 2033, trailing a CAGR of 6.51% during the forecast period. Surging number of research and deve...